Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration

Update Il y a 4 ans
Reference: NCT01134055

Woman and Man

Extract

The purpose of this study is to determine the safety and efficacy of different dosage regimens of pazopanib eye drops for the treatment of neovascular age-related macular degeneration.


Inclusion criteria

  • Macular degeneration


Links